• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Illumina expects EU order to keep Grail a separate company

September 20, 2021 by David Barret Leave a Comment

September 20, 2021

By Foo Yun Chee

BRUSSELS (Reuters) -Illumina Inc expects an EU order to keep recently acquired Grail Inc as a separate company, the U.S. life sciences company said on Monday, hours after EU antitrust regulators warned of interim measures for closing the deal before their approval.

The company is likely to face other measures on top of the hold separate order, however, with the EU competition enforcer sending a warning to other companies.

Illumina finalised the Grail takeover last month and said it would hold the company separate while waiting for a European Commission decision on the deal, defying EU merger rules against gun-jumping.

Previous instances of gun-jumping have resulted in companies being hit with million-euro fines. Sanctions can be as much as 10% of a company’s global turnover.

“We had anticipated that the Commission would seek to impose a hold separate order, and this is the reason why it has already voluntarily agreed to such an arrangement; their proposals are based on Illumina’s voluntary undertakings,” Illumina said in a statement.

It said it would discuss certain changes suggested by the EU in the coming days.

The EU competition enforcer earlier on Monday said it had sent a statement of objections or charge sheet to the companies, setting out the interim measures it plans to take. It did not provide details.

Under EU merger rules, the competition watchdog can order companies to unwind their deals or sell off shares or assets acquired for violations.

Commission Vice-President Margrethe Vestager underlined the seriousness of Illumina’s actions, saying it was the first time companies had openly implemented a deal while regulators were still investigating.

“The standstill obligation is a cornerstone of our ex-ante merger control regime which aims at preventing harmful effects to competition while our review is ongoing,” she said in a statement.

The Commission said the interim measures aim to restore and maintain effective competition pending a final decision on the deal.

The Commission will make a final decision on the measures after receiving the companies’ response.

(Reporting by Foo Yun Chee in BrusselsEditing by Jan Harvey and Matthew Lewis)

Source Link Illumina expects EU order to keep Grail a separate company

David Barret
David Barret

Related posts:

  1. Lebanon agrees new government to tackle economic collapse
  2. India, Australia eye closer security ties as 9/11 anniversary marked
  3. Motor racing-Mercedes boss says F1 sprint format is ‘not fish, not meat’
  4. In Hungary, pope says anti-Semitism ‘fuse’ must not be allowed to burn

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • First-Of-Its-Kind Evidence Shows Bees Can Learn “Morse Code” – Well, Kinda
  • Humans Have A “Seventh Sense” That Lets You Touch Things From A Distance
  • The Longest Place Name Has 111 Letters – And It’s Visited By Millions Of People Each Year
  • We Now Know Why Neanderthal Faces Looked So Different To Our Own
  • Why Does Africa Have So Many Of The World’s Largest Land Animals?
  • This “Ant-Mimicking” Spider Produces Its Own Kind Of Milk And Nurses Its Babies
  • 1972 Was The Longest Year In Modern History – Here’s Why
  • Why Did “Magic Mushrooms” Evolve To Be Hallucinogenic – What’s In It For The Mushrooms?
  • Why Can’t You Domesticate All Wild Animals? The Process Relies On 6 Characteristics Few Mammals Possess
  • Meet Some Of Earth’s Mightiest Predators
  • Canada Officially Loses Its Measles Elimination Status After Nearly 30 Years. The US Is Not Far Behind
  • Two “Anomalies” Detected In Egypt’s Menkaure Pyramid Using Electrical Resistance Tomography
  • Invasive “Tree Of Heaven” Unleashes Hell As “Double Invasion” Sweeps Across Virginia
  • Hamman’s Crunch: A Man Covered His Nose And Mouth Whilst Sneezing And Ended Up In Hospital
  • “One Of The Most Beautiful Experiments In Evolutionary Biology”: What The Peppered Moth Taught Us About Evolution
  • Why Do Microwaved Eggs Explode When You Bite Into Them?
  • First-Ever At-Home LSD Microdosing Trial For Depression Sees 60 Percent Improvement In Symptoms
  • People Are Just Learning What A Baby Turkey Is Called
  • Enceladus’s North Pole Is Leaking Heat, Indicating Its Ocean Is Ancient And Boosting Prospects For Life
  • Speaking Multiple Languages May Be A Secret Weapon Against The Ravages Of Old Age
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version